NCT05403814

Brief Summary

The aim of this study as part of the SCOBES-AR project is to establish and test a protocol for implementation and usability of mixed reality-enhanced multidisciplinary screening tool for early detection of cognitive impairments in the elderly.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Apr 2022

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 25, 2022

Completed
10 days until next milestone

First Submitted

Initial submission to the registry

May 5, 2022

Completed
29 days until next milestone

First Posted

Study publicly available on registry

June 3, 2022

Completed
28 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2022

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2022

Completed
Last Updated

June 3, 2022

Status Verified

May 1, 2022

Enrollment Period

2 months

First QC Date

May 5, 2022

Last Update Submit

May 31, 2022

Conditions

Keywords

mixed realitymultimodal screeningcognitive impairmentsmart cognition

Outcome Measures

Primary Outcomes (11)

  • Brief Smell Identification Test.

    The test evaluates the olfactory functions. Scale 0-12 points: higher values indicate better olfactory performance.

    Day 1.

  • Food-Frequency-Index.

    This assessment evaluates the dietary behavior. Dietary behavior is classified as poor (\< 32 points), moderate (32-34 points), good (35-39 points), and very good (\> 39 points).

    Day 1.

  • Dementia-Detection-Test.

    The test evaluates the cognitive functions (recall of word list, number transcoding, semantic word fluency, digit span reverse). Scale 0-18 points: probability of dementia (0-8 points), light cognitive changes (9-12 points), healthy (13-18 points).

    Day 1.

  • Erlangen Test of Activities of Daily Living in Persons with Mild Dementia or Mild Cognitive Impairment: items "mobility" and "finances", performed with pen-and-paper.

    For each of the 2 items ("mobility" and "finances") a score 0-6 points is given. Higher score indicates better performance.

    Day 1.

  • Erlangen Test of Activities of Daily Living in Persons with Mild Dementia or Mild Cognitive Impairment: items "mobility" and "finances", performed with Virtual Reality.

    For each of the 2 items ("mobility" and "finances") a score 0-6 points is given using tailor-made software. Higher score indicates better performance.

    Day 1.

  • Trail-Making Test, performed with pen-and-paper.

    The test evaluates the cognitive abilities and consists of two parts: connecting numbers and connecting numbers and letters in ascending order. The time (sec.) to perform the task is measured using a stop watch. Shorter time indicates better performance.

    Day 1.

  • Trail-Making Test, performed with Augmented Reality.

    The test evaluates the cognitive abilities and consists of two parts: connecting numbers and connecting numbers and letters in ascending order. The time (sec.) to perform the task is measured using a tailor-made software. Shorter time indicates better performance.

    Day 1.

  • Reaction Time Test, performed with contact plates.

    The test evaluates the complex reactivity (eye-hand, eye-leg and eye-hand-leg reactions) in response to visual signals displayed in a randomized order. The time (sec.) to perform the task is measured using a stop watch. Shorter time indicates better performance.

    Day 1.

  • Reaction Time Test, performed with smartphone mobile application.

    The test evaluates the complex reactivity (eye-hand, eye-leg and eye-hand-leg reactions) in response to visual signals displayed in a randomized order. The time (sec.) to perform the task is measured using mobile application. Shorter time indicates better performance.

    Day 1.

  • Dual Task Assessments, performed with direct observation.

    The assessment measures the influence of a cognitive task on gait parameters. Time to complete the task (sec.), number of steps and walking speed (steps/min.) will be calculated for the single task (walking) and the double task (walking and counting). Bigger difference between the parameters in both tasks indicates cognitive declines.

    Day 1.

  • Dual Task Assessments, performed with Augmented Reality.

    The assessment measures the influence of a cognitive task on gait parameters. Time to complete the task (sec.), number of steps and walking speed (steps/min.) will be calculated for the single task (walking) and the double task (walking and counting) using tailor-made software. Bigger difference between the parameters in both tasks indicates cognitive declines.

    Day 1.

Secondary Outcomes (2)

  • Usability evaluation using video observations.

    Day 1.

  • Usability evaluation using questionnaire.

    Day 1.

Interventions

observational screening procedure (no intervention)

Eligibility Criteria

Age60 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Residents of the city of Graz and Graz suburbs

You may qualify if:

  • Healthy individuals aged 60-75 years
  • Interest in participating in the study
  • Signed written informed consent form

You may not qualify if:

  • Clinical diagnosis of mild cognitive impairment or dementia
  • Clinical diagnosis of mental illness (e.g. depression, psychosis)
  • Reduced mobility (walking aid, wheelchair)
  • Aided hearing or visual impairment
  • Participation in any other cognitive training study within the last 6 months
  • Present guardianship according to the provisions of the Austrian adult protection law

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

FH-Joanneum

Graz, Styria, 8020, Austria

RECRUITING

Related Links

MeSH Terms

Conditions

Cognitive Dysfunction

Condition Hierarchy (Ancestors)

Cognition DisordersNeurocognitive DisordersMental Disorders

Study Officials

  • Wolfgang Staubmann, MSc

    FH Joanneum

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 5, 2022

First Posted

June 3, 2022

Study Start

April 25, 2022

Primary Completion

July 1, 2022

Study Completion

October 1, 2022

Last Updated

June 3, 2022

Record last verified: 2022-05

Locations